2023
DOI: 10.1016/j.ijpx.2023.100195
|View full text |Cite
|
Sign up to set email alerts
|

Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…They encapsulate the drug in their matrix, which allows the administration of the drug orally, topically, or parenterally, with specific, targeted properties with controlled or delayed release. This formulation increases the bioavailability of hydrophobic drugs and enables combining several compounds in one hydrogel matrix [25][26][27][28]. Considering the above-discussed properties of hydrogels, these matrices can be used as a promising delivery system for low soluble hydrophobic therapeutic agents such as curcumin.…”
Section: Hydrogelsmentioning
confidence: 99%
“…They encapsulate the drug in their matrix, which allows the administration of the drug orally, topically, or parenterally, with specific, targeted properties with controlled or delayed release. This formulation increases the bioavailability of hydrophobic drugs and enables combining several compounds in one hydrogel matrix [25][26][27][28]. Considering the above-discussed properties of hydrogels, these matrices can be used as a promising delivery system for low soluble hydrophobic therapeutic agents such as curcumin.…”
Section: Hydrogelsmentioning
confidence: 99%